Porcilis Porcoli Diluvac Forte (--) **SURRENDERED** - Emulsion for injection
Porcilis Porcoli Diluvac Forte (--) **SURRENDERED** - Emulsion for injection
Not authorised
- Escherichia coli, fimbrial adhesin F5
- Escherichia coli, fimbrial adhesin F4ab
- Escherichia coli, fimbrial adhesin F4ac
- Escherichia coli, fimbrial adhesin F6
- Escherichia coli, LT toxoid
Product identification
Medicine name:
Porcilis Porcoli Diluvac Forte (--) **SURRENDERED** - Emulsion for injection
Active substance:
- Escherichia coli, fimbrial adhesin F5
- Escherichia coli, fimbrial adhesin F4ab
- Escherichia coli, fimbrial adhesin F4ac
- Escherichia coli, fimbrial adhesin F6
- Escherichia coli, LT toxoid
Target species:
-
Pig (sow)
-
Pig (sow, nullipar)
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Escherichia coli, fimbrial adhesin F5Presentation_strength:at least 100 SR80 Reference:Hse Index:0
-
Escherichia coli, fimbrial adhesin F4abPresentation_strength:at least 100 SR80 Reference:Hse Index:1
-
Escherichia coli, fimbrial adhesin F4acPresentation_strength:at least 100 SR80 Reference:Hse Index:2
-
Escherichia coli, fimbrial adhesin F6Presentation_strength:at least 100 SR80 Reference:Hse Index:3
-
Escherichia coli, LT toxoidPresentation_strength:at least 100 SR80 Reference:Hse Index:4
Pharmaceutical form:
-
Emulsion for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Pig (sow)
-
Not applicable0dayZero days
-
-
Pig (sow, nullipar)
-
Not applicable0dayZero days
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AB02
Legal status of supply:
-
Medicinal product subject to medical prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Liechtenstein
-
Lithuania
-
Luxembourg
-
Malta
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone) - Council Directive 81/851/EEC
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International B.V.
Responsible authority:
- European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 7/05/2024
Bulgarian (PDF)
Published on: 7/05/2024
Croatian (PDF)
Published on: 7/05/2024
Czech (PDF)
Published on: 7/05/2024
Danish (PDF)
Published on: 7/05/2024
Dutch (PDF)
Published on: 7/05/2024
Estonian (PDF)
Published on: 7/05/2024
Finnish (PDF)
Published on: 7/05/2024
French (PDF)
Published on: 7/05/2024
German (PDF)
Published on: 7/05/2024
Greek (PDF)
Published on: 7/05/2024
Hungarian (PDF)
Published on: 7/05/2024
Italian (PDF)
Published on: 7/05/2024
Latvian (PDF)
Published on: 7/05/2024
Lithuanian (PDF)
Published on: 7/05/2024
Maltese (PDF)
Published on: 7/05/2024
Norwegian (PDF)
Published on: 7/05/2024
Polish (PDF)
Published on: 7/05/2024
Portuguese (PDF)
Published on: 7/05/2024
Romanian (PDF)
Published on: 7/05/2024
Slovak (PDF)
Published on: 7/05/2024
Slovenian (PDF)
Published on: 7/05/2024
Spanish (PDF)
Published on: 7/05/2024
Swedish (PDF)
Published on: 7/05/2024
How useful was this page?:
